Evidence map›Paper›PMID 41678256›Full record

ArticleMicrobial genomics2026

Resolving plasmid-encoded carbapenem resistance dynamics and reservoirs in a hospital setting through nanopore sequencing.

Ela Sauerborn, Rhys T White, Anna-Lena Kalteis, Daniel Gygax, Ebenezer Foster-Nyarko, Nina Wantia, Friedemann Gebhardt, Lara Urban

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ela SauerbornHelmholtz AI-Institute, Helmholtz Center Munich, Munich, Germany.
Rhys T WhiteNew Zealand Institute for Public Health and Forensic Science, Health Security, Porirua, New Zealand.
Anna-Lena KalteisDepartment of Preclinical Medicine, Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.
Daniel GygaxHelmholtz AI-Institute, Helmholtz Center Munich, Munich, Germany.
Ebenezer Foster-NyarkoDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK.
Nina WantiaDepartment of Preclinical Medicine, Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.
Friedemann GebhardtDepartment of Preclinical Medicine, Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany.
Lara UrbanHelmholtz AI-Institute, Helmholtz Center Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing resistance of

Indexed as

Anti-Bacterial Agentsbeta-Lactam ResistanceCarbapenemsCitrobacterPlasmidsBacterial Proteinsbeta-LactamasesEnterobacteriaceae InfectionsGenome, BacterialHospitalsHumansMultigene FamilyNanopore SequencingPhylogenyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemscarbapenem resistance reservoirsclinical resistance surveillancelong-read nanopore sequencingstrain and plasmid clustering

Identifiers

PMID41678256
PMCPMC12900256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.